BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32713333)

  • 1. Mass Spectrometric (MS) Analysis of Proteins and Peptides.
    Jayathirtha M; Dupree EJ; Manzoor Z; Larose B; Sechrist Z; Neagu AN; Petre BA; Darie CC
    Curr Protein Pept Sci; 2021; 22(2):92-120. PubMed ID: 32713333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass spectrometric analysis of post-translational modifications (PTMs) and protein-protein interactions (PPIs).
    Ngounou Wetie AG; Woods AG; Darie CC
    Adv Exp Med Biol; 2014; 806():205-35. PubMed ID: 24952184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Methods Employed in Mass Spectrometric Analysis of Posttranslational Modifications (PTMs) and Protein-Protein Interactions (PPIs).
    Yakubu RR; Nieves E; Weiss LM
    Adv Exp Med Biol; 2019; 1140():169-198. PubMed ID: 31347048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of contribution of protein phosphorylation in the development of the diseases].
    Zavialova MG; Zgoda VG; Nikolaev EN
    Biomed Khim; 2017 Mar; 63(2):101-114. PubMed ID: 28414281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometry-based proteomics analyses of post-translational modifications and proteoforms in human pituitary adenomas.
    Li J; Zhan X
    Biochim Biophys Acta Proteins Proteom; 2021 Mar; 1869(3):140584. PubMed ID: 33321259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel alternative splicing biomarkers for breast cancer with LC/MS/MS and RNA-Seq.
    Zhang F; Deng CK; Wang M; Deng B; Barber R; Huang G
    BMC Bioinformatics; 2020 Dec; 21(Suppl 9):541. PubMed ID: 33272210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass Spectrometry for Proteomics-Based Investigation.
    Woods AG; Sokolowska I; Ngounou Wetie AG; Channaveerappa D; Dupree EJ; Jayathirtha M; Aslebagh R; Wormwood KL; Darie CC
    Adv Exp Med Biol; 2019; 1140():1-26. PubMed ID: 31347039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How many human proteoforms are there?
    Aebersold R; Agar JN; Amster IJ; Baker MS; Bertozzi CR; Boja ES; Costello CE; Cravatt BF; Fenselau C; Garcia BA; Ge Y; Gunawardena J; Hendrickson RC; Hergenrother PJ; Huber CG; Ivanov AR; Jensen ON; Jewett MC; Kelleher NL; Kiessling LL; Krogan NJ; Larsen MR; Loo JA; Ogorzalek Loo RR; Lundberg E; MacCoss MJ; Mallick P; Mootha VK; Mrksich M; Muir TW; Patrie SM; Pesavento JJ; Pitteri SJ; Rodriguez H; Saghatelian A; Sandoval W; Schlüter H; Sechi S; Slavoff SA; Smith LM; Snyder MP; Thomas PM; Uhlén M; Van Eyk JE; Vidal M; Walt DR; White FM; Williams ER; Wohlschlager T; Wysocki VH; Yates NA; Young NL; Zhang B
    Nat Chem Biol; 2018 Feb; 14(3):206-214. PubMed ID: 29443976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of stable and transient protein-protein interactions: Past, present, and future.
    Ngounou Wetie AG; Sokolowska I; Woods AG; Roy U; Loo JA; Darie CC
    Proteomics; 2013 Feb; 13(3-4):538-57. PubMed ID: 23193082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteome-wide profiling and mapping of post translational modifications in human hearts.
    Bagwan N; El Ali HH; Lundby A
    Sci Rep; 2021 Jan; 11(1):2184. PubMed ID: 33500497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splice-Junction-Based Mapping of Alternative Isoforms in the Human Proteome.
    Lau E; Han Y; Williams DR; Thomas CT; Shrestha R; Wu JC; Lam MPY
    Cell Rep; 2019 Dec; 29(11):3751-3765.e5. PubMed ID: 31825849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal Settings of Mass Spectrometry Open Search Strategy for Higher Confidence.
    Li D; Lu S; Liu W; Zhao X; Mai Z; Zhang G
    J Proteome Res; 2018 Nov; 17(11):3719-3729. PubMed ID: 30265008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linear and Differential Ion Mobility Separations of Middle-Down Proteoforms.
    Garabedian A; Baird MA; Porter J; Jeanne Dit Fouque K; Shliaha PV; Jensen ON; Williams TD; Fernandez-Lima F; Shvartsburg AA
    Anal Chem; 2018 Feb; 90(4):2918-2925. PubMed ID: 29359922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix-assisted laser desorption ionization mass spectrometry: applications in peptide and protein characterization.
    Zaluzec EJ; Gage DA; Watson JT
    Protein Expr Purif; 1995 Apr; 6(2):109-23. PubMed ID: 7606158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Human Proteoform Atlas: a FAIR community resource for experimentally derived proteoforms.
    Hollas MAR; Robey MT; Fellers RT; LeDuc RD; Thomas PM; Kelleher NL
    Nucleic Acids Res; 2022 Jan; 50(D1):D526-D533. PubMed ID: 34986596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The next level of complexity: crosstalk of posttranslational modifications.
    Venne AS; Kollipara L; Zahedi RP
    Proteomics; 2014 Mar; 14(4-5):513-24. PubMed ID: 24339426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of cardiac troponin proteoforms by top-down mass spectrometry.
    Tiambeng TN; Tucholski T; Wu Z; Zhu Y; Mitchell SD; Roberts DS; Jin Y; Ge Y
    Methods Enzymol; 2019; 626():347-374. PubMed ID: 31606082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotype classification and characterisation of the rotavirus SA11 VP6 protein using mass spectrometry and two-dimensional gel electrophoresis.
    Emslie KR; Molloy MP; Barardi CR; Jardine D; Wilkins MR; Bellamy AR; Williams KL
    Funct Integr Genomics; 2000 May; 1(1):12-24. PubMed ID: 11793218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and localization of protein modifications by high resolution tandem mass spectrometry.
    Meng F; Forbes AJ; Miller LM; Kelleher NL
    Mass Spectrom Rev; 2005; 24(2):126-34. PubMed ID: 15389861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized sample-processing time and peptide recovery for the mass spectrometric analysis of protein digests.
    Terry DE; Umstot E; Desiderio DM
    J Am Soc Mass Spectrom; 2004 Jun; 15(6):784-94. PubMed ID: 15144968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.